236 related articles for article (PubMed ID: 23810379)
21. Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations.
Huang-Doran I; Tomlinson P; Payne F; Gast A; Sleigh A; Bottomley W; Harris J; Daly A; Rocha N; Rudge S; Clark J; Kwok A; Romeo S; McCann E; Müksch B; Dattani M; Zucchini S; Wakelam M; Foukas LC; Savage DB; Murphy R; O'Rahilly S; Barroso I; Semple RK
JCI Insight; 2016 Oct; 1(17):e88766. PubMed ID: 27766312
[TBL] [Abstract][Full Text] [Related]
22. The Role of PIK3R1 in Metabolic Function and Insulin Sensitivity.
Tsay A; Wang JC
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628845
[TBL] [Abstract][Full Text] [Related]
23. Activation of PI3K/Akt signaling by n-terminal SH2 domain mutants of the p85α regulatory subunit of PI3K is enhanced by deletion of its c-terminal SH2 domain.
Hofmann BT; Jücker M
Cell Signal; 2012 Oct; 24(10):1950-4. PubMed ID: 22735814
[TBL] [Abstract][Full Text] [Related]
24. The p85 regulatory subunit of PI3K mediates cAMP-PKA and insulin biological effects on MCF-7 cell growth and motility.
Di Zazzo E; Feola A; Zuchegna C; Romano A; Donini CF; Bartollino S; Costagliola C; Frunzio R; Laccetti P; Di Domenico M; Porcellini A
ScientificWorldJournal; 2014; 2014():565839. PubMed ID: 25114970
[TBL] [Abstract][Full Text] [Related]
25. Short syndrome-an expanding phenotype.
Singh A; Arora R; Singh P; Kapoor S
Indian Pediatr; 2013 Apr; 50(4):414-6. PubMed ID: 23665600
[TBL] [Abstract][Full Text] [Related]
26. miR-100-3p inhibits the adipogenic differentiation of hMSCs by targeting PIK3R1 via the PI3K/AKT signaling pathway.
Wang T; Zhong D; Qin Z; He S; Gong Y; Li W; Li X
Aging (Albany NY); 2020 Nov; 12(24):25090-25100. PubMed ID: 33221758
[TBL] [Abstract][Full Text] [Related]
27. PI3K-p110α mediates the oncogenic activity induced by loss of the novel tumor suppressor PI3K-p85α.
Thorpe LM; Spangle JM; Ohlson CE; Cheng H; Roberts TM; Cantley LC; Zhao JJ
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):7095-7100. PubMed ID: 28630349
[TBL] [Abstract][Full Text] [Related]
28. Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K.
Lucas CL; Zhang Y; Venida A; Wang Y; Hughes J; McElwee J; Butrick M; Matthews H; Price S; Biancalana M; Wang X; Richards M; Pozos T; Barlan I; Ozen A; Rao VK; Su HC; Lenardo MJ
J Exp Med; 2014 Dec; 211(13):2537-47. PubMed ID: 25488983
[TBL] [Abstract][Full Text] [Related]
29. Somatic loss of PIK3R1 may sensitize breast cancer to inhibitors of the MAPK pathway.
Turturro SB; Najor MS; Yung T; Portt L; Malarkey CS; Abukhdeir AM; Cobleigh MA
Breast Cancer Res Treat; 2019 Sep; 177(2):325-333. PubMed ID: 31209687
[TBL] [Abstract][Full Text] [Related]
30. Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphoinositide 3-kinase.
Terauchi Y; Tsuji Y; Satoh S; Minoura H; Murakami K; Okuno A; Inukai K; Asano T; Kaburagi Y; Ueki K; Nakajima H; Hanafusa T; Matsuzawa Y; Sekihara H; Yin Y; Barrett JC; Oda H; Ishikawa T; Akanuma Y; Komuro I; Suzuki M; Yamamura K; Kodama T; Suzuki H; Yamamura K; Kodama T; Suzuki H; Koyasu S; Aizawa S; Tobe K; Fukui Y; Yazaki Y; Kadowaki T
Nat Genet; 1999 Feb; 21(2):230-5. PubMed ID: 9988280
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of PI3K binding to activators by serine phosphorylation of PI3K regulatory subunit p85alpha Src homology-2 domains.
Lee JY; Chiu YH; Asara J; Cantley LC
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14157-62. PubMed ID: 21825134
[TBL] [Abstract][Full Text] [Related]
32. Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases.
Dornan GL; Burke JE
Front Immunol; 2018; 9():575. PubMed ID: 29616047
[TBL] [Abstract][Full Text] [Related]
33. [A case of PIK3R1 gene variation induced SHORT syndrome].
Cao BY; Wu D; Gong CX
Zhonghua Er Ke Za Zhi; 2021 Mar; 59(3):228-230. PubMed ID: 33657699
[TBL] [Abstract][Full Text] [Related]
34. TGF-β promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85α.
Hamidi A; Song J; Thakur N; Itoh S; Marcusson A; Bergh A; Heldin CH; Landström M
Sci Signal; 2017 Jul; 10(486):. PubMed ID: 28676490
[TBL] [Abstract][Full Text] [Related]
35. p85alpha regulates osteoblast differentiation by cross-talking with the MAPK pathway.
Wu X; Chen S; Orlando SA; Yuan J; Kim ET; Munugalavadla V; Mali RS; Kapur R; Yang FC
J Biol Chem; 2011 Apr; 286(15):13512-21. PubMed ID: 21324896
[TBL] [Abstract][Full Text] [Related]
36. Variant PIK3R1 Hypermorphic Mutation and Clinical Phenotypes in a Family with Short Statures, Mild Immunodeficiency and Lymphoma.
Hauck F; Magg T; Krolo A; Bilic I; Hirschmugl T; Laass M; Rösen-Wolff A; Luksch H; Boztug K; Roesler J
Klin Padiatr; 2017 May; 229(3):113-117. PubMed ID: 28561224
[No Abstract] [Full Text] [Related]
37. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
Valverde AM; Lorenzo M; Pons S; White MF; Benito M
Mol Endocrinol; 1998 May; 12(5):688-97. PubMed ID: 9605931
[TBL] [Abstract][Full Text] [Related]
38. Growth factor receptor-binding protein 10 (Grb10) as a partner of phosphatidylinositol 3-kinase in metabolic insulin action.
Deng Y; Bhattacharya S; Swamy OR; Tandon R; Wang Y; Janda R; Riedel H
J Biol Chem; 2003 Oct; 278(41):39311-22. PubMed ID: 12783867
[TBL] [Abstract][Full Text] [Related]
39. Defining How Oncogenic and Developmental Mutations of PIK3R1 Alter the Regulation of Class IA Phosphoinositide 3-Kinases.
Dornan GL; Stariha JTB; Rathinaswamy MK; Powell CJ; Boulanger MJ; Burke JE
Structure; 2020 Feb; 28(2):145-156.e5. PubMed ID: 31831213
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of insulin signaling in endothelial cells by protein kinase C-induced phosphorylation of p85 subunit of phosphatidylinositol 3-kinase (PI3K).
Maeno Y; Li Q; Park K; Rask-Madsen C; Gao B; Matsumoto M; Liu Y; Wu IH; White MF; Feener EP; King GL
J Biol Chem; 2012 Feb; 287(7):4518-30. PubMed ID: 22158866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
